Protein_Domain

Part:BBa_K3672002

Designed by: Mingyao Wang   Group: iGEM20_SCU-WestChina   (2020-10-26)
Revision as of 06:30, 26 October 2020 by Registry (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


CILY，collagen I targeting probe

CILY possessed inhibitory activity on type I collagen-induced platelet aggregation and the release of ATP. As recorded, it has a higher binding affinity (Kd:10nM) to collagen type I than the modified version, SILY, but the modification allowed dermatan sulfate to be conjugated to the terminus of the peptide.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
Parameters
None